Physician profile
William Wardell
NPI 1063974319
$48,027.24
in general payments reported to CMS, 2019-2025
11 companies · $47K in 2025
The $47K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $491 · 2022: $72.32 · 2023: $59.85 · 2024: $171 · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $47K · Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $46,666.66 |
| Food and Beverage | $796.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $23,495.84 | 2025 | Biobrace 23mm |
| Arthrex, INC. | $20,000.00 | 2025 | |
| Smith+Nephew, INC. | $3,519.68 | 2025 | Mini-Open Latarjet, Microraptor, Aetos Shoulder System |
| Stryker Corporation | $437.01 | 2021-2025 | Triathlon, Trident, T2 Alpha |
| Baxter Healthcare | $142.08 | 2021-2022 | |
| Si-Bone, INC. | $114.76 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $102.69 | 2025 | |
| Hydrocision, INC. | $81.57 | 2025 | Tenjet |
| Medartis INC. | $79.63 | 2024 | Aptus |
| Davol INC. | $39.74 | 2024 | Arista Ah Flexitip |
| Biomarin Pharmaceutical INC. | $14.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wardell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.